Showing results (1771-1780 of 2,301) with videos related to

Sort By:
Pageof 231
ACS Medicinal Chemistry Letters|April 20, 2018
Optimization of a β-Lactam Scaffold for Antibacterial Activity via the Inhibition of Bacterial Type I Signal PeptidaseChien-Hung Yeh, Shawn I Walsh, Arryn Craney, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 17, 2012
Determinants of health-related quality of life in people with Parkinson's disease: a path analysisSze-Ee Soh, Jennifer L McGinley, Jennifer J Watts, et al.
Physiologia Plantarum|June 7, 2026
Ice Nucleation and Freezing Consequences in Perennial PlantsLia Lamacque, Nicolas Dusart, Pierre Amato, et al.
Blood Advances|October 27, 2020
Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamideScott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Experimental Hematology|December 26, 2001
Identification and characterization of Magmas, a novel mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transductionP T Jubinsky, A Messer, J Bender, et al.
BMJ Open|November 4, 2022
Patient experiences of codesigned rehabilitation interventions in hospitals: a rapid reviewJonathan P McKercher, Susan C Slade, Jalal A Jazayeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantationM R Bishop, S R Tarantolo, Z S Pavletic, et al.
Dalton Transactions (Cambridge, England : 2003)|March 25, 2011
Solvothermal aluminophosphate zeotype synthesis with ionic liquid precursorsDavid S Wragg, Grace M Fullerton, Peter J Byrne, et al.
Journal of the American Chemical Society|January 13, 2006
NO-releasing zeolites and their antithrombotic propertiesPaul S Wheatley, Anthony R Butler, Michael S Crane, et al.
Bone Marrow Transplantation|March 11, 2018
Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or olderZain A Bashey, Xu Zhang, Stacey Brown, et al.
Pageof 231